Mr. Mark Agne is a Board Member of Silver Creek Pharmaceuticals. He is a Board Member of the Nature Conservancy, Hawai'i and the Hawai'i Community Foundation. He was at Goldman Sachs from 1997 until his retirement in 2016. He was made a partner in 2006 and held various senior leadership roles in Asia, including the head of Asia Equity Trading and Head of Securities (Equities and Fixed Income), Japan. He was a member of the Asian Operating Committee, Asian Risk Committee, Asian Operational Risk Committee and Asian Suitability Committee. He serves as an Angel Investor.